CXCL8 and ovarian neoplasm: This suggests that IL-8 may influence the efficacy of oncolytic Adv therapy, IL-8 blockade together with adenovirus can influence TIL proliferation and activation when co-cultured with TANs isolated from ovarian tumors (81).